Recruiting Thyroid Cancer Studies in Philadelphia
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131 NaI) uptake and allow for I-131 treatment in people with RET fusion-positive radioiodine-ref...
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioacti...
About Thyroid Cancer Clinical Trials in Philadelphia
Thyroid cancer develops in the thyroid gland and is the most common endocrine malignancy. Most thyroid cancers are highly treatable with excellent prognosis. Types include papillary, follicular, medullary, and anaplastic thyroid cancer.
There are currently 2 thyroid cancer clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 43 participants. Research is being sponsored by Massachusetts General Hospital, Children's Hospital of Philadelphia. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thyroid Cancer Clinical Trials in Philadelphia — FAQ
Are there thyroid cancer clinical trials in Philadelphia?
Yes, there are 2 thyroid cancer clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What thyroid cancer treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for thyroid cancer.
Data updated March 2, 2026 from ClinicalTrials.gov